Objective
Primary objective
Assess the operational feasibility and acceptability of use of Truenat MTB Plus and MTB-RIF Dx testing on the Molbio Truenat platform within a mobile TB active case finding service in Yogyakarta, Indonesia.
Secondary objectives
For bacteriologically confirmed tuberculosis cases, compare time to result for individuals diagnosed using decentralised Truenat MTB Plus and MTB-RIF Dx against time to result for individuals diagnosed using centralised geneXpert testing.
Compare the time to treatment commencement for decentralised Truenat MTB Plus and MTB-RIF Dx to centralised Xpert testing.